CD30 CAR T Cells, Relapsed CD30 Expressing Lymphoma (RELY-30)

NCT02917083 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Hodgkin's Lymphoma
Non-Hodgkin Lymphoma

Interventions

GENETIC: CAR T Cells

Sponsor

Baylor College of Medicine

Collaborators

[object Object]